Interleukins

Interleukins are signaling proteins (a type of cytokine) released by white blood cells and other cells to coordinate the body's immune and inflammatory responses. They act like chemical messengers, telling other cells to multiply, attack invaders, or calm down inflammation. Different interleukins (IL-1, IL-6, IL-8, and others) have distinct jobs, and abnormal levels can signal chronic inflammation or cancer.

Origin

The term was coined in 1979 at the Second International Lymphokine Workshop in Switzerland, combining the Latin inter (between) and Greek leukos (white), to describe molecules that carry signals between white blood cells. As more were discovered, they were numbered sequentially (IL-1, IL-2, and so on).

Significance in Asbestos Context

Asbestos fibers lodged in tissue cause long-lasting inflammation, and interleukins are central to that process. IL-1β and IL-6 in particular are released when asbestos damages mesothelial cells, and chronically high IL-6 has been linked to the development and progression of mesothelioma. It can drive tumor growth and contribute to the fatigue, weight loss, and anemia many patients experience. Some interleukin levels are being studied as blood biomarkers to help detect mesothelioma earlier or to monitor response to treatment, and certain newer therapies aim to block these inflammatory signals. For patients, this is part of why asbestos-related cancers can develop decades after exposure: the inflammatory signaling never fully shuts off.

Example Sentence

Her oncologist explained that the high interleukin-6 level in her bloodwork was contributing to her fatigue and was consistent with active mesothelioma.

Related Terms

Cytokines, Chronic Inflammation, Mesothelioma, Biomarkers, IL-6, Tumor Microenvironment

Notes

• Ask your oncologist whether inflammatory markers like IL-6 or C-reactive protein (CRP) are being tracked, as they can correlate with disease activity and prognosis in mesothelioma.
• If you are enrolled in or considering a clinical trial, ask whether any interleukin-targeted therapies (such as anti-IL-6 agents) are available for your disease subtype.
• Keep copies of all lab reports that include cytokine or inflammatory marker results. They may support the medical-causation portion of a legal claim by documenting chronic inflammation linked to asbestos exposure.
• Elevated interleukins are not specific to asbestos disease (infections and autoimmune conditions also raise them), so interpretation requires the full clinical picture.